Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Has results × Health Promotion × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Cyclophosphamide 194 pembrolizumab 160 Carboplatin 149 Gemcitabine 136 Cisplatin 135 Paclitaxel 129 Docetaxel 119 Radiotherapy 118 Bevacizumab 117 Rituximab 113 Dexamethasone 103 Nivolumab 100 fludarabine 89 Capecitabine 85 Fluorouracil 83 fludarabine phosphate 77 Doxorubicin 75 Pemetrexed 72 Oxaliplatin 70 Etoposide 67 Cytarabine 67 Leucovorin 66 Erlotinib Hydrochloride 62 Bortezomib 60 Irinotecan 59 Calcium Dobesilate 58 Filgrastim 57 Methotrexate 54 Lenalidomide 52 Cetuximab 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04081298 2023-07-03

MiVSEEV

Fred Hutchinson Cancer Center

Phase NA Terminated

20 enrolled 34 charts

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡